Wed, October 10, 2018
Tue, October 9, 2018
Mon, October 8, 2018
Fri, October 5, 2018
Thu, October 4, 2018
Wed, October 3, 2018
Tue, October 2, 2018
Mon, October 1, 2018
Fri, September 28, 2018
Thu, September 27, 2018
Wed, September 26, 2018
Tue, September 25, 2018
Mon, September 24, 2018
Fri, September 21, 2018
Thu, September 20, 2018
Wed, September 19, 2018
Tue, September 18, 2018
Mon, September 17, 2018

David Lebovitz Maintained (ALNY) at Hold with Decreased Target to $87 on, Sep 28th, 2018


//stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-87-on-sep-28th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation



David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Decreased Target from $93 to $87 on, Sep 28th, 2018.

David has made no other calls on ALNY in the last 4 months.



There are 6 other peers that have a rating on ALNY. Out of the 6 peers that are also analyzing ALNY, 0 agree with David's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with David


  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $117 on, Thursday, September 13th, 2018
  • Ritu Baral of "Cowen & Co." Maintained at Buy with Decreased Target to $147 on, Monday, August 13th, 2018
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $123 on, Monday, August 13th, 2018
  • Christopher Marai of "Nomura" Maintained at Sell with Decreased Target to $73 on, Monday, August 13th, 2018
  • Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $125 on, Monday, August 13th, 2018
  • Madhu Kumar of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $230 on, Monday, August 13th, 2018

Publication Contributing Sources